Skip to main content
Download PDF

Correction to: Histone deacetylase inhibitor ITF2357 (givinostat) reverts transformed phenotype and counteracts stemness in in vitro and in vivo models of human glioblastoma

Journal of Cancer Research and Clinical Oncology volume 145, page 2411 (2019)Cite this article

The Original Article was published on 24 November 2018

Correction to: Journal of Cancer Research and Clinical Oncology (2019) 145:393–409 https://doi.org/10.1007/s00432-018-2800-8

In the original publication, the 6th author’s first name and the last name was inverted and incorrectly published. The correct author name is Letizia Ferella.

Author information

Affiliations

  1. Department of Radiotherapy, Policlinico Umberto I, “Sapienza” University of Rome, Rome, Italy

    Francesco Marampon & Vincenzo Tombolini

  2. Research Center, Italfarmaco SpA, Cinisello Balsamo, Milan, Italy

    Flavio Leoni, Giuliana Porro, Elisabetta Galbiati, Pietro Pozzi & Paolo Mascagni

  3. Radiobiology Laboratory, Department of Biotechnological and Applied Clinical Sciences, University of L’Aquila, Via vetoiossnc, Coppito II, L’aquila, Italy

    Andrea Mancini, Letizia Ferella, Giovanni Luca Gravina & Claudio Festuccia

  4. Laboratory of Pharmacology, Department of Biotechnological and Applied Clinical Sciences, University of L’Aquila, L’aquila, Italy

    Ilaria Pietrantoni & Roberto Maggio

  5. Department of Molecular and Translational Medicine, University of Brescia, Brescia, Italy

    Silvia Codenotti & Alessandro Fanzani

  6. Division of Radiation Oncology, Department of Biotechnological and Applied Clinical Sciences, University of L’Aquila, L’aquila, Italy

    Letizia Ferella & Giovanni Luca Gravina

  7. Department of Experimental Medicine, “Sapienza” University of Rome, Rome, Italy

    Francesca Megiorni

  8. Experimental Pharmacology Unit, Istituto Nazionale Tumori-IRCCS-Fondazione G. Pascale, Naples, Italy

    Alfredo Budillon

Authors
  1. Francesco Marampon
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Flavio Leoni
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Andrea Mancini
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Ilaria Pietrantoni
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Silvia Codenotti
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Letizia Ferella
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Francesca Megiorni
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Giuliana Porro
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Elisabetta Galbiati
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. Pietro Pozzi
    View author publications

    You can also search for this author in PubMed Google Scholar

  11. Paolo Mascagni
    View author publications

    You can also search for this author in PubMed Google Scholar

  12. Alfredo Budillon
    View author publications

    You can also search for this author in PubMed Google Scholar

  13. Roberto Maggio
    View author publications

    You can also search for this author in PubMed Google Scholar

  14. Vincenzo Tombolini
    View author publications

    You can also search for this author in PubMed Google Scholar

  15. Alessandro Fanzani
    View author publications

    You can also search for this author in PubMed Google Scholar

  16. Giovanni Luca Gravina
    View author publications

    You can also search for this author in PubMed Google Scholar

  17. Claudio Festuccia
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Claudio Festuccia.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Marampon, F., Leoni, F., Mancini, A. et al. Correction to: Histone deacetylase inhibitor ITF2357 (givinostat) reverts transformed phenotype and counteracts stemness in in vitro and in vivo models of human glioblastoma. J Cancer Res Clin Oncol 145, 2411 (2019). https://doi.org/10.1007/s00432-019-02980-6

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00432-019-02980-6